Oxford-based provider of blockchain-enabled pharmaceutical supply chain management software for drug makers and their partners.
Founded in 2017 and headquartered in Oxford, UK, Veratrak Limited offers a subscription platform that centralizes pharmaceutical supply chain operations in a secure dashboard. It serves pharmaceutical companies, contract manufacturers and contract development and manufacturing organizations, and reports serving more than 150 organizations. CEO Jason Lacombe leads the company. In March 2022 it raised GBP 5.53 million in a seed round at a post-money valuation of GBP 28.09 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in